Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 24,900 shares, a growth of 43.1% from the October 15th total of 17,400 shares. Based on an average daily volume of 13,300 shares, the days-to-cover ratio is presently 1.9 days. Currently, 4.1% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on RKDA shares. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a research report on Wednesday, August 21st. StockNews.com assumed coverage on Arcadia Biosciences in a report on Friday. They issued a “sell” rating for the company.

Arcadia Biosciences Price Performance

Arcadia Biosciences stock traded down $0.96 during midday trading on Friday, hitting $2.90. 64,881 shares of the stock were exchanged, compared to its average volume of 18,779. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $5.34. The firm has a market cap of $3.94 million, a P/E ratio of -0.68 and a beta of 1.27. The company has a 50 day moving average price of $3.34 and a two-hundred day moving average price of $3.02.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). The business had revenue of $1.31 million for the quarter, compared to analysts’ expectations of $0.95 million. Arcadia Biosciences had a negative return on equity of 52.63% and a negative net margin of 110.61%. During the same period in the previous year, the firm posted ($2.64) earnings per share. As a group, analysts predict that Arcadia Biosciences will post -1.7 EPS for the current year.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.